Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milataxel in Malignant Mesothelioma
NCT00685204Phase 2Unknown
- Sponsor
- Taxolog, Inc.
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milataxel in malignant mesothelioma, sponsored by Taxolog, Inc.. Status: unknown.
02
Drugs
milataxel
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00685204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685204.